Skip to main content
Petragen
  • Home
  • About
  • Science & Research
  • Publications
  • Team
  • Careers
  • Contact

Research

Publications

Peer-reviewed research underpinning Petragen’s therapeutic platform in ENPP1 biology and pathological mineralization.

  • Catalysis-independent ENPP1 protein signaling regulates mammalian bone mass Zimmerman K, Li X, von Kroge S, Stabach P, Lester ER, Chu EY, Srivastava S, Somerman MJ, Tommasini SM, Busse B, Schinke T, Carpenter TO, Oheim R, Braddock DT Journal of Bone and Mineral Research · 2022 Demonstrates that ENPP1 regulates bone mass through catalysis-independent protein signaling pathways, uncovering a dual role for ENPP1 beyond its enzymatic function and providing the mechanistic basis for Petragen's platform.
  • Counter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesis Foster BL, Ao M, Willoughby C, Soenjaya Y, Holm E, Lukashova L, Tran AB, Wimer HF, Zerfas PM, Nociti FH Jr, Kantovitz KR, Quan BD, Sone ED, Goldberg HA, Somerman MJ International Journal of Oral Science · 2015 Defines how TNAP and NPP1 act as counter-regulatory phosphatases to control cementum formation on tooth roots, directly informing Petragen's approach to periodontal regeneration.
  • Hypophosphatasia-associated deficiencies in mineralization and gene expression in cultured dental pulp cells obtained from human teeth Rodrigues TL, Foster BL, Silverio KG, Martins L, Casati MZ, Sallum EA, Nociti FH Jr, Somerman MJ Journal of Endodontics · 2012 Demonstrates that hypophosphatasia disrupts mineralization and odontoblast gene expression in human dental pulp cells, connecting ENPP1/pyrophosphate biology to the HPP dental phenotype.
  • Central role of pyrophosphate in acellular cementum formation Foster BL, Nagatomo KJ, Tso HW, Tran AB, Nociti FH Jr, Narisawa S, Yadav MC, McKee MD, Millan JI, Somerman MJ PLoS ONE · 2012 Establishes pyrophosphate as the central regulator of acellular cementum formation, showing that cementoblasts actively tune local PPi levels to control mineralization on tooth root surfaces.
  • Correction of hypophosphatasia-associated mineralization deficiencies in vitro by phosphate/pyrophosphate modulation in periodontal ligament cells Rodrigues TL, Nagatomo KJ, Foster BL, Nociti FH Jr, Somerman MJ Journal of Periodontology · 2011 Shows that correcting the phosphate/pyrophosphate ratio rescues mineralization in HPP periodontal ligament cells, supporting the therapeutic rationale for modulating ENPP1 activity in periodontal disease.
  • Hypercementosis associated with ENPP1 mutations and GACI Thumbigere-Math V, Alqadi A, Guzman Vega F, Owczarczak-Garstecka SC, Tso HW, Chu EY, Chojnowski J, Foster BL, Somerman MJ, Braddock DT Journal of Dental Research · 2018 Supports the biological connection between ENPP1 dysfunction and cementum accumulation in human GACI patients, helping frame the rationale for periodontal regeneration.
  • Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators Chu EY, Chavez MB, Hu Y, Foster BL, Somerman MJ, Braddock DT Bone · 2020 Provides direct evidence that genetic and pharmacologic modulation of pyrophosphate regulators influences cementogenesis, validating the target mechanism for Petragen's periodontal program.

Petragen

Advancing precision therapeutics for diseases of pathological mineralization

Contact

Questions about our programs, science, or partnership opportunities? Our team is ready to connect.

Go to Contact page

© 2026 Petragen. All rights reserved.

Content on this website is provided for informational purposes only and does not constitute medical advice.

This website may include forward-looking statements regarding investigational programs that are subject to risks and uncertainties.